Search results for "biopharma 4.0"

Article Oligonucleotide Development and Manufacturing Workflow
Click here to view >> Learn more on key considerations when setting up an oligonucleotide workflow with this infographic.

Article Successful Development of Scalable AAV Processes: Part 2 of 2
Watch the Q&A interview >> In the second of a two-part series, Anki Magnusson, Staff Research Engineer, Protein and Viral Production, and Åsa Hagner-McWhirter, PhD, Senior Scientist, Bio…

Resource DiPIA 2021 virtual conference
Real science, real interactions, real time For the first time ever, the DiPIA conference will virtually connect you with researchers around the globe. Get inspired by leading experts in academ…

Article Increasing mRNA Capabilities and Capacity for Growing Market Needs
Click here to read more >> The success of the mRNA vaccine market is fueling high demand for mRNA, resulting in a critical need to address the manufacturing bottlenecks.

Article Key Process Considerations for Therapeutic Oligonucleotides
Click here to read the article >> Learn more about scalable solutions for developing and manufacturing oligonucleotide therapeutics.

Article Cell-free Expression Systems Pose Cell Culture Alternative
Cell-free expression is promising in preclinical applications, but still presents challenges to scale up for commercial production. Feliza Mirasol Among the challenges in upstrea…

Article Novavax Reports on Two Vaccine Efficacy Studies
Novavax’s COVID-19 vaccine is 90.4% effective and maintains efficacy when administered with an influenza vaccine. Novavax announced on June 14, 2021, results from two studies of is recombinant…

Article Commercial Production of Gene Therapies Using Suspension or Adherent Cell Lines
This article will explore the traditional path from the laboratory to the clinic and how the fixed-bed technology provides an alternative solution to meet commercial demands. By Alex Chatel and …

Article Cytiva and Pall Corporation Investing 1.5 Billion USD Over Two Years to Meet Growing Demand for Biotechnology Solutions
Click here to read more >> An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher (NYSE: DHR) Corporation, will expand manufacturing capacity and services acros…

Article See How Solis BioDyne Turned to Cytiva to Support Production Ramp-Up
Click here to read more>> Solis BioDyne is one of the many life sciences companies that experienced a dramatic increase in demand for its solutions during the COVID-19 pandemic. In a collabora…

Previous PageNext Page